Critics argue that the FDA's caution could restrict access to a potentially beneficial compound, advocating for a more balanced approach that considers BPC-157's therapeutic potential
A clinical study found that applying 0.5% bisabolol daily for 8 weeks produced an average 9% decrease in skin pigmentation
While widely available through peptide vendors, it does not carry the manufacturing standards, safety testing, or oversight of approved medications or supplements
Why people explore GHK-Cu/Epitalon GHK-Cu activates fibroblasts to lay down new collagen and elastin and remodel the extracellular matrix, the scaffold your skin's firmness, bounce, and smoothness rest on
Glycation products The APs level was effectively inhibited in ChT + amlodipine (18%), ChT + aminoguanidine (19%), and ChT + NAC (34%) compared with ChT